Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.
NCT04165499 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2020-05-13
Summary
The objective of this study is to evaluate the effect of the combination of a combination of plant extracts (BSL\_EP026) on blood and urine uricemia levels in individuals with levels at the limit of the values considered normal or moderately high.
Conditions
- Hyperuricemia
Interventions
- COMBINATION_PRODUCT
-
Combination of Plant Extracts (BSL_EP026)
Each participant will consume 2 capsules daily, in the morning and in the evening.
- COMBINATION_PRODUCT
-
Control
Each participant will consume 2 capsules daily, in the morning and in the evening.
Sponsors & Collaborators
-
Clínica Dr. Miguel Quesada
collaborator UNKNOWN -
Biosearch S.A.
lead INDUSTRY
Principal Investigators
-
Miguel Quesada, MD, PhD · Clínica Dr. Quesada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-11
- Primary Completion
- 2020-03-20
- Completion
- 2020-03-20
Countries
- Spain
Study Locations
More Related Trials
-
Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine Oxidase
NCT06876909 ·Status: COMPLETED ·Phase: NA
-
Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms
NCT04012294 ·Status: UNKNOWN ·Phase: PHASE3
-
Hyperuricemia on Hypertension and Metabolic Syndrome
NCT01157936 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Lesinurad Monotherapy Extension Study in Gout
NCT01650246 ·Status: COMPLETED ·Phase: PHASE3
-
Lesinurad and Allopurinol Combination Extension Study in Gout
NCT01808131 ·Status: COMPLETED ·Phase: PHASE3
-
Nutraceutical on Hyperuricemia
NCT04161872 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Allopurinol Treatment on Insulin Resistance
NCT02008968 ·Status: UNKNOWN ·Phase: NA
-
Combining Lesinurad With Allopurinol in Inadequate Responders
NCT01493531 ·Status: COMPLETED ·Phase: PHASE3
-
Prebiotics and the Management of Hyperuricemia
NCT06420401 ·Status: RECRUITING ·Phase: NA
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
NCT02956278 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
NCT01407874 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
NCT03906006 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NCT07002762 ·Status: RECRUITING ·Phase: NA
-
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia
NCT03185793 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
NCT05504083 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
NCT05007392 ·Status: COMPLETED ·Phase: PHASE3
-
Gout Dose Response Study
NCT00955981 ·Status: COMPLETED ·Phase: PHASE2
-
Allopurinol Combination Study
NCT01001338 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
NCT00978653 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines
NCT02797028 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
NCT04060173 ·Status: COMPLETED ·Phase: PHASE1
-
The Intervention of Multi-vitamin With Minerals to Hyperuricemia
NCT03218709 ·Status: UNKNOWN ·Phase: PHASE4